Psychedelic psychotropics are gaining widespread attention. What used to be classified as illicit drugs is now becoming an accepted part of psychiatric and medical treatments for a range of issues, including depression and PTSD.

Joseph Araujo is a behavioral pharmacologist and Mindset Pharma cofounder, director and chief scientific officer. Mindset Pharma is a Canadian-based drug discovery and development company focused on creating optimized and patentable next-generation psychedelic medicines to treat neurological and psychiatric disorders.